Please enable JavaScript to continue using this application.

Compare $ANVS vs $INMB | Chartloom

Compare

$ANVS vs $INMB

Annovis Bio Inc · INmune Bio Inc

ANVS

Annovis Bio Inc

INMB

INmune Bio Inc

Compare $ANVS vs $INMB

Comparing Annovis Bio Inc and INmune Bio Inc

ANVSAnnovis Bio Inc

INMBINmune Bio Inc

ANVSAnnovis Bio Inc

Market cap

$42M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-66.8%

52W performance

-46.7%

FCF yield

-103.4%

INMBINmune Bio Inc

Market cap

$50M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-100.0%

YTD performance

22.7%

52W performance

-6.0%

FCF yield

-31.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ANVS

INMB

Detailed metrics comparison

ANVS

Annovis Bio Inc

INMB

INmune Bio Inc

Market Cap

ANVS$42M

INMB$50M

Enterprise Value

ANVS$23M

INMB$32M

Price

ANVS$1.21

INMB$1.89

P/E Ratio

ANVSN/A

INMBN/A

P/S Ratio

ANVS0.00x

INMB1,071.30x

EV/Sales

ANVS0.00x

INMB703.08x

EV/EBITDA

ANVS0.00x

INMB0.00x

P/B Ratio

ANVS16.11x

INMB2.63x

P/FCF Ratio

ANVSN/A

INMBN/A

EV/FCF

ANVS-0.54x

INMB-2.02x

PEG Ratio

ANVSN/A

INMBN/A

Forward P/E (NTM)

ANVSN/A

INMBN/A

Forward P/S (NTM)

ANVSN/A

INMBN/A

Revenue (TTM)

ANVS$0

INMB$0

Revenue Growth (YoY)

ANVSN/A

INMB-100.0%

Forward Rev Growth

ANVS507.4%

INMB150.6%

Gross Margin (TTM)

ANVS0.0%

INMB0.0%

Operating Margin (TTM)

ANVS0.0%

INMB0.0%

EBITDA Margin (TTM)

ANVS0.0%

INMB0.0%

Net Margin (TTM)

ANVS0.0%

INMB0.0%

FCF Margin (TTM)

ANVSN/A

INMBN/A

Net Income (TTM)

ANVS$-50M

INMB$-18M

FCF (TTM)

ANVS$-43M

INMB$-16M

EPS (TTM)

ANVS-$1.32

INMB-$0.69

ROE (TTM)

ANVS-31808.0%

INMB-8287.0%

ROA (TTM)

ANVS-25878.0%

INMB-6223.0%

ROIC (TTM)

ANVS-31808.0%

INMB-8287.0%

Cash

ANVS$19M

INMB$18M

Debt

ANVS$0

INMB$0

Net Cash/Debt

ANVS$19M

INMB$18M

Current Ratio (TTM)

ANVS3.47x

INMB4.04x

Quick Ratio (TTM)

ANVS2.95x

INMB3.94x

Debt/Equity (TTM)

ANVS0.00x

INMB0.00x

Debt/Assets (TTM)

ANVS0.0%

INMB0.0%

Interest Coverage (TTM)

ANVSN/A

INMBN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

INMB0.00x

Beta

ANVS1.32

INMB0.91

52W Performance

ANVS-46.7%

INMB-6.0%

YTD Performance

ANVS-66.8%

INMB22.7%

% from 52W High

ANVS-78.0%

INMB-27.3%

% from 52W Low

ANVS16.3%

INMB73.4%

Asset Turnover (TTM)

ANVS0.00x

INMB0.00x

FCF Yield (TTM)

ANVS-103.4%

INMB-31.3%

Earnings Yield (TTM)

ANVS-118.1%

INMB-36.6%

Dividend Yield (TTM)

ANVSN/A

INMBN/A

Rule of 40

ANVS0.0

INMB-100.0

EV/GP/RG

ANVSN/A

INMBN/A

Ticker research

View ANVS research View INMB research

Metric	ANVS Annovis Bio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$42M	$50M
Enterprise Value	$23M	$32M
Price	$1.21	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,071.30x
EV/Sales	0.00x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	507.4%	150.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-50M	$-18M
FCF (TTM)	$-43M	$-16M
EPS (TTM)	-$1.32	-$0.69
ROE (TTM)	-31808.0%	-8287.0%
ROA (TTM)	-25878.0%	-6223.0%
ROIC (TTM)	-31808.0%	-8287.0%
Financial Health
Cash	$19M	$18M
Debt	$0	$0
Net Cash/Debt	$19M	$18M
Current Ratio (TTM)	3.47x	4.04x
Quick Ratio (TTM)	2.95x	3.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.91
52W Performance	-46.7%	-6.0%
YTD Performance	-66.8%	22.7%
% from 52W High	-78.0%	-27.3%
% from 52W Low	16.3%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-103.4%	-31.3%
Earnings Yield (TTM)	-118.1%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View INMB research

Valuation

P/S Ratio

ANVS

0.00x

INMB

1,071.30x

EV/FCF

INMB

-2.02x

ANVS

-0.54x

Growth & revenue

Revenue Growth TTM

INMB

-100.0%

Forward Revenue Growth

ANVS

507.4%

INMB

150.6%

Profitability & performance

Gross Margin

ANVS

0.0%

INMB

0.0%

ROE

INMB

-8287.0%

ANVS

-31808.0%

FCF Yield %

INMB

-31.3%

ANVS

-103.4%

52-Week Performance

INMB

-6.0%

ANVS

-46.7%

Detailed metrics comparison

ANVS

Annovis Bio Inc

INMB

INmune Bio Inc

Market Cap

ANVS$42M

INMB$50M

Enterprise Value

ANVS$23M

INMB$32M

Price

ANVS$1.21

INMB$1.89

P/E Ratio

ANVSN/A

INMBN/A

P/S Ratio

ANVS0.00x

INMB1,071.30x

EV/Sales

ANVS0.00x

INMB703.08x

EV/EBITDA

ANVS0.00x

INMB0.00x

P/B Ratio

ANVS16.11x

INMB2.63x

P/FCF Ratio

ANVSN/A

INMBN/A

EV/FCF

ANVS-0.54x

INMB-2.02x

PEG Ratio

ANVSN/A

INMBN/A

Forward P/E (NTM)

ANVSN/A

INMBN/A

Forward P/S (NTM)

ANVSN/A

INMBN/A

Revenue (TTM)

ANVS$0

INMB$0

Revenue Growth (YoY)

ANVSN/A

INMB-100.0%

Forward Rev Growth

ANVS507.4%

INMB150.6%

Gross Margin (TTM)

ANVS0.0%

INMB0.0%

Operating Margin (TTM)

ANVS0.0%

INMB0.0%

EBITDA Margin (TTM)

ANVS0.0%

INMB0.0%

Net Margin (TTM)

ANVS0.0%

INMB0.0%

FCF Margin (TTM)

ANVSN/A

INMBN/A

Net Income (TTM)

ANVS$-50M

INMB$-18M

FCF (TTM)

ANVS$-43M

INMB$-16M

EPS (TTM)

ANVS-$1.32

INMB-$0.69

ROE (TTM)

ANVS-31808.0%

INMB-8287.0%

ROA (TTM)

ANVS-25878.0%

INMB-6223.0%

ROIC (TTM)

ANVS-31808.0%

INMB-8287.0%

Cash

ANVS$19M

INMB$18M

Debt

ANVS$0

INMB$0

Net Cash/Debt

ANVS$19M

INMB$18M

Current Ratio (TTM)

ANVS3.47x

INMB4.04x

Quick Ratio (TTM)

ANVS2.95x

INMB3.94x

Debt/Equity (TTM)

ANVS0.00x

INMB0.00x

Debt/Assets (TTM)

ANVS0.0%

INMB0.0%

Interest Coverage (TTM)

ANVSN/A

INMBN/A

Net Debt/EBITDA (TTM)

ANVS0.00x

INMB0.00x

Beta

ANVS1.32

INMB0.91

52W Performance

ANVS-46.7%

INMB-6.0%

YTD Performance

ANVS-66.8%

INMB22.7%

% from 52W High

ANVS-78.0%

INMB-27.3%

% from 52W Low

ANVS16.3%

INMB73.4%

Asset Turnover (TTM)

ANVS0.00x

INMB0.00x

FCF Yield (TTM)

ANVS-103.4%

INMB-31.3%

Earnings Yield (TTM)

ANVS-118.1%

INMB-36.6%

Dividend Yield (TTM)

ANVSN/A

INMBN/A

Rule of 40

ANVS0.0

INMB-100.0

EV/GP/RG

ANVSN/A

INMBN/A

Ticker research

View ANVS research View INMB research

Metric	ANVS Annovis Bio Inc	INMB INmune Bio Inc
Market & Valuation
Market Cap	$42M	$50M
Enterprise Value	$23M	$32M
Price	$1.21	$1.89
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,071.30x
EV/Sales	0.00x	703.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	16.11x	2.63x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.54x	-2.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	-100.0%
Forward Rev Growth	507.4%	150.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-50M	$-18M
FCF (TTM)	$-43M	$-16M
EPS (TTM)	-$1.32	-$0.69
ROE (TTM)	-31808.0%	-8287.0%
ROA (TTM)	-25878.0%	-6223.0%
ROIC (TTM)	-31808.0%	-8287.0%
Financial Health
Cash	$19M	$18M
Debt	$0	$0
Net Cash/Debt	$19M	$18M
Current Ratio (TTM)	3.47x	4.04x
Quick Ratio (TTM)	2.95x	3.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.32	0.91
52W Performance	-46.7%	-6.0%
YTD Performance	-66.8%	22.7%
% from 52W High	-78.0%	-27.3%
% from 52W Low	16.3%	73.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-103.4%	-31.3%
Earnings Yield (TTM)	-118.1%	-36.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-100.0
EV/GP/RG	N/A	N/A
Ticker research	View ANVS research	View INMB research